Product Images Levetiracetam

levETIRAcetam is a prescribed medication that comes with an insert on how to use it. The medicine should be kept out of reach from children and stored within the appropriate temperature range of 20-26°C (63-77°F) and excursions up to 15-30°C (59-86°F). The pharmaceutical company that manufactured this item is located in Westminster, MD 21157, and the product is repackaged by RemedyRepack Inc. The text also includes the NDC number, which acts as a unique identifier for the product.*

This text is describing a formula to calculate clearance rate for female patients based on their age, weight, and serum creatinine levels. The calculation involves multiplying the patient's weight in kilograms by 140 minus their age in years, then dividing that number by 72% of their serum creatinine level in milligrams per deciliter. The resulting clearance rate can then be adjusted for body surface area by multiplying it by the patient's BSA (in square meters) divided by 1.73.*

This appears to be a table showing the number of participants (N) in a study comparing the efficacy of a placebo group (n=95) to two groups receiving different doses of levetiracetam (1000 mg/day and 3000 mg/day, with N=97 and N=101, respectively). The purpose and context of the study is not specified, so further information would be needed to fully understand the significance of these results.*

This appears to be a chart or table showing the percentages of patients (labeled "Y of Patients") in two groups (labeled "Placebo" and "Levetiracetam") with sample sizes of 97 and 101, respectively. Without additional context, it is not clear what the percentages represent or what condition or treatment is being studied.*

This is a table showing the percentage of patients in two groups - Placebo and Levetiracetam. The percentage of patients in the Placebo group is 43.1% while the percentage in the Levetiracetam group is 19.6%. The table suggests that Levetiracetam was statistically significant compared to Placebo, however, the context of the study or trial is not available.*